13F HOLDINGS REPORT
Atlas Venture Life Science Advisors, LLC
Quarter ended Q4 2023 · Filed November 13, 2023 · Accession 0001104659-23-117225
Total Value
$645.6M
Positions
15
Other Managers
0
Confidential Omitted
No
Holdings (15)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Disc Medicine, Inc. | IRON | 2,745,335 | $129.0M | 19.98% |
| 2 | Day One Biopharmaceuticals, Inc. | DAWN | 7,608,394 | $93.4M | 14.46% |
| 3 | Dyne Therapeutics, Inc. | DYN | 9,885,449 | $88.6M | 13.72% |
| 4 | Kymera Therapeutics, Inc. | KYMR | 5,858,262 | $81.4M | 12.61% |
| 5 | Third Harmonic Bio, Inc. | 88427A107 | 10,907,859 | $69.7M | 10.80% |
| 6 | Replimune Group, Inc. | REPL | 2,098,300 | $35.9M | 5.56% |
| 7 | Vigil Neuroscience, Inc. | 92673K108 | 5,836,874 | $31.5M | 4.87% |
| 8 | Generation Bio, Co. | 37148K100 | 8,279,484 | $31.4M | 4.86% |
| 9 | Aerovate Therapeutics, Inc. | 008064107 | 2,039,249 | $27.7M | 4.29% |
| 10 | Ikena Oncology, Inc. | 45175G108 | 5,018,178 | $21.7M | 3.37% |
| 11 | Akero Therapeutics, Inc. | 00973Y108 | 359,251 | $18.2M | 2.81% |
| 12 | AvroBio, Inc. | 05455M100 | 4,541,381 | $7.0M | 1.08% |
| 13 | Xilio Therapeutics, Inc. | XLO | 2,759,344 | $5.8M | 0.90% |
| 14 | Dianthus Therapeutics, Inc. | DNTH | 236,979 | $3.2M | 0.50% |
| 15 | Spero Therapeutics, Inc. | SPRO | 1,013,438 | $1.2M | 0.19% |